Featured series 
Tag: Marc Lipsitch
-
Nation & World
Don’t let delta disrupt learning, expert says
Marc Lipsitch, an epidemiologist and director of the Harvard T.H. Chan School of Public Health’s Center for Communicable Disease Dynamics, says COVID vaccines for children should not be rushed and a return to in-person learning can still be navigated.
-
Nation & World
Immunologist says technology can keep up with COVID variants
Despite worries that a new coronavirus variant may be able to evade vaccines just being distributed, a Harvard public health expert expressed confidence in the same technology that produced the vaccines in record time.
-
Nation & World
K-12 education appears on downward slide as pandemic continues
U.S. K-12 schools are struggling through a difficult school year, with a significant number of children who are learning remotely becoming chronically absent, a Harvard education experts said Tuesday.
-
Nation & World
Highly infectious coronavirus variant dampens prospects for summer return to normal
Will the British variant’s transmissibility upset summer plans?
-
Nation & World
U.S. failed to control pandemic, but vaccination provides ‘chance to get next phase right’
Experts said the complex rollout of a coronavirus vaccine gives the U.S. a chance for a win after the virus gained the upper hand in its initial phase.
-
Nation & World
Americans are weary of lockdowns, but if COVID surges, what then?
If not a new lockdown, how do we slow the coronavirus in the future, researchers ask.
-
Nation & World
University community rallies to deal with COVID-19 crisis
Harvard faculty, students, researchers, and staff are working with hospitals, first responders, state and city leaders, and many more across Greater Boston to support the response to the coronavirus pandemic.
-
Nation & World
Could a new test identify immunity?
Harvard epidemiologist Marc Lipsitch outlined several scenarios — most of them bad — for getting America back to work
-
Nation & World
‘Worry about 4 weeks from now,’ epidemiologist warns
Harvard epidemiologist says U.S. needs to dramatically increase testing and social distancing, adding to the closings, cancellations, and shifts online.
-
Nation & World
Coronavirus screening may miss two-thirds of infected travelers entering U.S.
Harvard epidemiologist Marc Lipsitch says two-thirds of travelers with coronavirus who are entering U.S. may have been missed by screening efforts.
-
Nation & World
So how bad is coronavirus in U.S.? We don’t know yet
A rapid expansion of coronavirus testing is needed to understand the extent and nature of the epidemic’s track in the U.S., Harvard experts said.
-
Nation & World
A big coronavirus mystery: What about the children?
A key unanswered question in the coronavirus epidemic concerns why children seem to be getting fewer or less-serious infections from the new contagion.
-
Nation & World
Coronavirus likely now ‘gathering steam’
Harvard’s Marc Lipsitch said evidence indicates that the international cordon keeping coronavirus cases bottled up in China is a leaky one, and it’s likely that the relative handful of global cases reported so far are undercounted. If true, that will lead to widespread illness internationally, including in the U.S.
-
Nation & World
What we know — and don’t know — about the coronavirus outbreak
As the number of coronavirus cases rapidly grows, the Gazette spoke with Professor of Epidemiology Marc Lipsitch, an expert in the spread of infectious disease and director of the Center for Communicable Disease Dynamics.
-
Nation & World
Fighting the flu at less than full strength
Panelists focused on gaps in vaccination in a Harvard Chan School discussion on the flu.
-
Nation & World
The threat from superbugs
Hospital stewardship programs, community education, and legal changes to allow pharmaceutical companies to profit longer from new antibiotics are among reforms that experts suggest to fight drug-resistant bacteria.
-
Nation & World
Underprepared for the next pandemic
A lack of “surge” capacity plagues pandemic flu preparations around the world, as public health officials, scientists, and pharmaceutical industry scientists work to streamline vaccine production as well as improve surveillance, communication, and other public health practices before the next new ailment hits.
-
Nation & World
Flu’s coming, but which kind?
With a new flu virus appearing in China in April and a new SARS-like respiratory ailment appearing in the Middle East, the Gazette sat down with Harvard epidemiologist Marc Lipsitch to talk about the upcoming flu season.
-
Nation & World
Fears of bioterrorism or an accidental release
In a preview of what is likely now playing out in a closed-door meeting of the World Health Organization, a cadre of experts on infectious disease gathered Feb. 15 at the Harvard School of Public Health (HSPH) to debate whether efforts to combat a deadly form of flu have actually increased the risk to public…
-
Nation & World
Lipsitch catches the flu in action
Harvard School of Public Health Epidemiology Professor Marc Lipsitch is helping the government plan its response to H1N1 flu.
-
Nation & World
School of Public Health professor advising feds on H1N1 policy
One thing certain about the flu is uncertainty, according to Marc Lipsitch, a professor of epidemiology at the Harvard School of Public Health and a prominent authority on the spread…
-
Nation & World
Around the Schools: Harvard School of Public Health
A new center focusing on mathematical modeling of drug resistance, seasonal infectious diseases, and intervention allocation will be established at the Harvard School of Public Health.
-
Nation & World
Outwitting mutating flu during a pandemic
In a global influenza pandemic, small stockpiles of a secondary flu medication – if used early in local outbreaks – could extend the effectiveness of primary drug stockpiles, according to…
-
Nation & World
Containment buys time but…
Containing an emerging bird flu pandemic at its source will probably only delay – not stop – the illness’ spread because of likely multiple introductions of the pathogen, assert researchers…
-
Nation & World
New findings about protection against pneumococcal disease
Before the advent of the pneumococcal vaccine, known as Prevnar, S. pneumoniae caused millions of ear infections each year, half a million episodes of bacterial pneumonia, and life- threatening cases…